(Q39346196)

11 September 2017

Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma (English)

2 references

11 September 2017

https://api.crossref.org/works/10.1002/IJC.2910160415

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

8 April 2022

author name string

W. J. Halliday

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51836

8 April 2022

A. E. Maluish

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51836

8 April 2022

J. H. Little

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51836

8 April 2022

N. C. Davis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A51836

8 April 2022

language of work or name

English

0 references

publication date

1 October 1975

1 reference

11 September 2017

15 October 1975

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=51836

full work available at URL

8 April 2022

number of pages

14

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910160415

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910160415

8 April 2022

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

International Journal of Cancer

8 April 2022

published in

1 reference

11 September 2017

16

1 reference

11 September 2017

645-658

1 reference

11 September 2017

4

1 reference

Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910160415

Detection of Anti-tumour Cell Mediated Immunity and Serum Blocking Factors in Cancer Patients by the Leucocyte Adherence Inhibition Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910160415

Evidence for tumor-specific immunity in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910160415

Lymphocyte toxicity test in clinical melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910160415

Fluorescent antibody studies in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910160415

Cell-mediated immunity in malignant melanoma

21 January 2018

1

1

1340

Cochran

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease

8 April 2022

2

4

67

Cochran

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Immunization with Irradiated Tumour Cells and Specific Lymphocyte Cytotoxicity in Malignant Melanoma

8 April 2022

4

2

305

Currie

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells

8 April 2022

5

14

427

De Vries

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cellular and humoral immunity against human malignant melanoma

8 April 2022

6

8

344

Fossati

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Macrophage migration inhibition with mouse tumor antigens: Properties of serum and peritoneal cells during tumor growth and after tumor loss

8 April 2022

8

3

113

Halliday

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition

8 April 2022

Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leucocyte adherence inhibition test

9

volume

2

page(s)

349

0 references

11

10

467

Halliday

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Leukocyte adherence inhibition: a simple test for cell-mediated tumour immunity and serum blocking factors.

8 April 2022

12

9

477

Halliday

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

In-vitro interactions between antitumour antibodies and anti-antibodies in malignancy

8 April 2022

13

2

1481

Hartmann

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Demonstration of cell-mediated immunity to human neoplasms of various histological types

8 April 2022

15

7

1

Hellström

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.

8 April 2022

16

8

185

Hellström

1971

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.

8 April 2022

17

11

280

Hellström

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.

8 April 2022

18

11

245

Heppner

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cell-Mediated Immunity to Tumor Cells

8 April 2022

19

19

207

Herberman

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Antigen-mediated macrophage adherence inhibition

8 April 2022

20

13

107

Holán

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma

8 April 2022

22

283

329

Jehn

1970

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

A leukocyte adherence inhibition test for cell-mediated immunity

8 April 2022

23

51

198

Lampert

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cell-mediated immunity in patients with malignant melanoma

8 April 2022

26

87

523

Mackie

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Cell-Mediated Immunity and Specific Serum Factors in Human Cancer: The Leukocyte Adherence Inhibition Test2

8 April 2022

27

52

1415

Maluish

0 references

Quantitation of anti-tumor cell-mediated immunity by a lymphokine-Dependent reaction using small volumes of blood

28

17

131

Maluish

1975

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease

8 April 2022

32

6

87

Newberry

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Leukocyte adherence inhibition as measured by a radioisotopic technique for detection of cell-mediated tumor immunity

8 April 2022

33

14

833

Pierce

1974

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

In vitro study of cellular immunity against autochthonous human cancer

8 April 2022

34

9

417

Segall

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes

8 April 2022

36

9

274

Sjögren

1972

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

8 April 2022

37

33

2898

Takasugi

1973

1 reference

https://api.crossref.org/works/10.1002/IJC.2910160415

8 April 2022

Identifiers

1 reference

11 September 2017

1 reference